SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-004444
Filing Date
2019-05-08
Accepted
2019-05-08 16:03:16
Documents
69
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q edit-20190331x10q.htm 10-Q 2146462
2 EX-10.1 edit-20190331ex101b45bd0.htm EX-10.1 530351
3 EX-10.2 edit-20190331ex1028248a6.htm EX-10.2 75388
4 EX-10.3 edit-20190331ex1037376a1.htm EX-10.3 143818
5 EX-31.1 edit-20190331ex31132aec6.htm EX-31.1 19691
6 EX-31.2 edit-20190331ex3123b3f5e.htm EX-31.2 19222
7 EX-32.1 edit-20190331ex3219e1945.htm EX-32.1 13514
  Complete submission text file 0001558370-19-004444.txt   8261201

Data Files

Seq Description Document Type Size
8 EX-101.INS edit-20190331.xml EX-101.INS 1520376
9 EX-101.SCH edit-20190331.xsd EX-101.SCH 61530
10 EX-101.CAL edit-20190331_cal.xml EX-101.CAL 49709
11 EX-101.DEF edit-20190331_def.xml EX-101.DEF 200050
12 EX-101.LAB edit-20190331_lab.xml EX-101.LAB 513376
13 EX-101.PRE edit-20190331_pre.xml EX-101.PRE 366177
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37687 | Film No.: 19806584
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences